BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1546565)

  • 1. [Clinical significance of the stereological estimation of mean nuclear volume in human bladder carcinoma--relation to tumor grade, stage and prognosis].
    Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M; Yamabe H
    Hinyokika Kiyo; 1992 Jan; 38(1):25-9. PubMed ID: 1546565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables].
    Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M
    Hinyokika Kiyo; 1992 Dec; 38(12):1361-8. PubMed ID: 1288224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical prognostic factors in superficial cancer of the urinary bladder].
    Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
    Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
    J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of 300 patients with bladder cancer].
    Mori Y; Arima M; Shimada K; Shima H; Ihara H; Yabumoto H; Hosokawa S; Taguchi K; Ikoma F
    Hinyokika Kiyo; 1991 Oct; 37(10):1235-41. PubMed ID: 1755417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study of superficial bladder cancer with grade 3 components].
    Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
    Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment for 217 patients with bladder transitional carcinoma].
    Yu SL; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Wang H; Li YH
    Ai Zheng; 2006 Jan; 25(1):73-5. PubMed ID: 16405754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphometric study of transitional carcinoma of the bladder (II): analysis of 95 infiltrating tumors].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Arch Esp Urol; 1991 Apr; 44(3):251-6. PubMed ID: 1867505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
    Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
    Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical investigation of grade-up superficial bladder cancer].
    Noguchi S; Kubota Y; Masuda M; Shuin T; Yao M; Hosaka M
    Hinyokika Kiyo; 1995 Sep; 41(9):659-64. PubMed ID: 7484528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.